Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Faderl S, Talpaz M, Estrov Z, O’Brien S, Kurzrock R, Kantarjian HM (1999) The biology of chronic myeloid leukemia. N Engl J Med 341:164–172
2. Brück O, Blom S, Dufva O, Turkki R, Chheda H, Ribeiro A et al (2018) Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML. Leukemia 32:1643–1656
3. Kondĕlková K, Vokurková D, Krejsek J, Borská L, Fiala Z, Ctirad A (2010) Regulatory T cells (TREG) and their roles in immune system with respect to immunopathological disorders. Acta Med 53:73–77
4. D’Arena G, Vitale C, Coscia M, Festa A, Di Minno NMD, De Feo V et al (2017) Regulatory T cells and their prognostic relevance in hematologic malignancies. J Immunol Res 2017:1832968
5. Topalian SL, Drake CG, Pardoll DM (2012) Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity. Curr Opin Immunol 24:207–212